Correlation of response to antifibrotic treatment with adverse events to antifibrotic drugs in IPF patients from the real-world EMPIRE registry

Basit Öğe Kaydı
dc.contributor.authorJovanovic, Dragana
dc.contributor.authorSterclova, Martina
dc.contributor.authorMogulkoc, Nesrin
dc.contributor.authorLewandowska, Katarzyna
dc.contributor.authorMuller, Veronika
dc.contributor.authorHajkova, Marta
dc.contributor.authorKaeva, Biserka Jovkovska
dc.date.accessioned2021-05-03T20:37:02Z
dc.date.available2021-05-03T20:37:02Z
dc.date.issued2020
dc.departmentEge Üniversitesien_US
dc.description.abstract[No Abstract Available]en_US
dc.identifier.doi10.1183/13993003.congress-2020.3391
dc.identifier.issn0903-1936
dc.identifier.issn1399-3003
dc.identifier.urihttps://doi.org/10.1183/13993003.congress-2020.3391
dc.identifier.urihttps://hdl.handle.net/11454/70325
dc.identifier.volume56en_US
dc.identifier.wosWOS:000606501406407en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherEuropean Respiratory Soc Journals Ltden_US
dc.relation.ispartofEuropean Respiratory Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectIdiopathic pulmonary fibrosisen_US
dc.subjectTreatmentsen_US
dc.titleCorrelation of response to antifibrotic treatment with adverse events to antifibrotic drugs in IPF patients from the real-world EMPIRE registryen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu